ArticleHuman vaccines & immunotherapeutics2024

A novel anti-CD47 antibody with therapeutic potential for NK/T-cell lymphoma.

Liping Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.